P He, M Bai, J Hu, C Dong, S Sun… - Kidney and Blood Pressure …, 2020 - karger.com
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is a promising marker for the diagnosis of diabetic kidney disease (DKD), but its utility is currently debated. This meta …
C Lu, W Liu, Z Chen, L Hua, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background Dyslipidemia is a well-recognized risk factor for diabetic kidney disease (DKD) in patients with type 2 diabetes (T2D). Growing evidences have shown that compared with …
XY Tang, JB Zhou, FQ Luo, YP Han, W Zhao… - Renal failure, 2019 - Taylor & Francis
Objectives: Urine neutrophil gelatinase-associated lipocalin (NGAL) was found to increase in diabetic kidney disease (DKD). However, the clinical value of urine NGAL as diagnostic …
Background Currently, there is a lack of prediction markers for diabetic nephropathy (DN) in patients with type 1 and type 2 diabetes mellitus (T1DM/T2DM). The aim of this systematic …
C Lu, W Liu, X Ge, F Xu - Endocrine Connections, 2021 - ec.bioscientifica.com
The aim of the present study was to evaluate the association between adenosine deaminase (ADA) levels and diabetic kidney disease (DKD) in patients with type 2 diabetes …
C Lu, J Ma, J Su, X Wang, W Liu, X Ge - Endocrine Journal, 2021 - jstage.jst.go.jp
The present study was designed to explore whether serum stromal cell-derived factor-1 (SDF-1) levels were associated with diabetic kidney disease (DKD). Serum SDF-1 levels …
EAE Tony, MAA Abozaid, AA Aziz… - Journal of The …, 2024 - journals.lww.com
Background In liver cirrhosis, hemodynamic changes in splanchnic and systemic circulations are involved. Indeed, no established laboratory markers for altered renal …